Abstract
Background and Objective: Diabetes mellitus is often concomitant with hypertension, which manifests a 3-fold greater risk for cardiovascular disease (CVD). Recent studies suggest the ability of American (AG) and Korean red ginseng (KRG) species to improve diabetes control via complementary mechanisms. Additionally, a KRG-inherent component, ginsenoside Rg3, may moderate blood pressure (BP). Our objective, therefore, is to investigate the therapeutic potential of co-administration of Rg3-enriched Korean Red Ginseng (Rg3-KRG) and AG, added to conventional treatment, in the management of hypertension and glycemic control in type 2 diabetes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
